Bortezomib
CAS 179324-69-7
Visão geral
Boltezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. This includes those who have not been treated before and multiple myeloma. It is commonly used in combination with other drugs. It is given by injection
A Anant Labs fabrica e fornece impurezas de Bortezomib de alta qualidade para o mercado global. Nossas impurezas EP de Bortezomib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Dados Técnicos
Cat. No.ANT-BTZ-00
CAS179324-69-7
Fórmula Mol.C19H25BN4O4
Peso Mol.384.24 g/mol
IUPAC[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
SMILESB([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
InChIInChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1
Chave InChIGXJABQQUPOEUTA-RDJZCZTQSA-N
Note: We are upgrading our system, Cat No will change.
Sinônimos
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acidBortezomib179324-69-7VelcadePS-341LDP-341NSC-681239LDP 341Bortezomib accord69G8BD63PP
